Opsoclonus-myoclonus syndrome: A clinicopathological confrontation

Acta Neurologica Belgica

Volumn 106, Issue 3, 2006, Pages 142-146

  Baets, J ^a   Pals, P ^a   Bergmans, B ^a   Foncke, E ^a   Smets, K ^b   Hauman, H ^b   Vanderwergen, L ^c   Cras, Patrick ^a,d  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b Algemeen Ziekenhuis Sint Maarten   (Belgium)

^c Department of Neurology Heilig Hartziekenhuis ^*  (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Breast carcinoma; Immunoglobulins; NSCLC; Paraneoplastic syndrome; Plasmapheresis

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINUCLEAR ANTIBODY; CARBAMAZEPINE; CLONAZEPAM; CLOTIAPINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PIRACETAM;

ADULT; ARTICLE; ATAXIA; AUTOPSY; BLURRED VISION; BREAST CARCINOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DIPLOPIA; DISEASE ASSOCIATION; DRUG RESPONSE; DYSARTHRIA; ELECTROENCEPHALOGRAM; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALAISE; MASTECTOMY; MOTOR DYSFUNCTION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; OPSOCLONUS MYOCLONUS SYNDROME; PLASMAPHERESIS; THORAX RADIOGRAPHY; VERTIGO;

EID: 33750297001     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bataller L., Rosenfeld M. R., Graus F., Vilchez J. J., Cheung N. K. et al. Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann. Neurol., 2003, 53 (3): 347-353.
2. Bataller L., Graus F., Saiz A., Vilchez J. J. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain, 2001, 124 (Pt 2): 437-443.
3. Blaes F, Fuhlhuber V., Korfei M., Tschernatsch M., Behnisch W. et al. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann. Neurol., 2005, 58 (2): 313-317.
4. Caviness J. N., Forsyth P. A., Layton D. D., McPhee T. J. The movement disorder of adult opsoclonus. Mov. Disord., 1995, 10 (1): 22-27.
5. Cher L. M., Hochberg F. H., Teruya J., Nischke M., Valenzuela R. F et al. Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption. Cancer, 1995, 75 (7): 1678-1683.
6. Dale R. C. Childhood opsoclonus myoclonus. Lancet Neurol., 2003, 2 (5) : 270.
7. Deconinck N., Scaillon M., Segers V., Groswasser J. J., Dan B. Opsoclonus-myoclonus associated with celiac disease. Pediatr. Neurol., 2006, 34 (4): 312-314.
8. Dropcho E. J., Kline L. B., Riser J. Antineuronal (anti-Ri) antibodies in a patient with steroid-responsive opsoclonus-myoclonus. Neurology, 1993, 34 (1): 207-211.
9. Gatti G., Simsek S., Kurne A., Zurrida S., Naninato P. et al. Paraneoplastic neurological disorders in breast cancer. Breast, 2003, 12 (3): 203-207.
10. Glatz K., Meinck H. M., Wildemann B. Parainfectious opsoclonus-myoclonus syndrome: high dose intravenous immunoglobulins are effective. J. Neurol. Neurosurg. Psychiatry, 2003, 74 (2): 279-280.
11. Hersch B., Dalmau J., Dangond F., Gultekin S., Geller E. et al. Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody. Neurology, 1994, 44 (9): 1754-1755.
12. Luque A., Furneaux H.M., Ferziger R., Rosenblum M. K., Wray S. et al. Anti-Ri: an antibody with paraneoplastic opsoclonus and breast cancer. Ann. Neurol., 1991, 29 (3): 241-51.
13. Pranzatelli M. R. The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin. Neuropharmacol., 1996, 19 (1): 1-47.
14. Pranzatelli M. R., Chun K. Y., Moxness M., Tate E. D., Allsion T. J. Cerebrospinal fluid ACTH and cortisol in opsoclonus-myoclonus: effect of therapy. Pediatr. Neurol., 2005, 33 (2): 121-126.
15. Scaravilli F., An S. F., Groves M., Thom M. The neuropathology of paraneoplastic syndromes. Brain Pathol., 1999, 9 (2): 251-260.
16. Turkel S. B., Brumm V. L., Mitchell W. G., Tavare C. J. Mood and behavioral dysfunction with opsoclonus-myoclonus ataxia. J. Neuropsychiatry Clin. Neurosci., 2006, 18 (2): 239-241.
17. Van Everbroeck B., Quolin S., Boons J., Martin J. J., Cras P. A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease. J. Neurol. Neurosurg. Psychiatry, 2003, 74 : 1210-1214.
18. Verma A, Brozman B. Opsoclonus-myoclonus syndrome following Epstein-Barr virus infection. Neurology, 2002, 58 (7): 1131-1132.
19. Vigliani M.C., Palmucci L., Polo P., Mutani R., Schiffer D. et al. Paraneoplastic opsoclonus-myoclonus associated with renal cell carcinoma and responsive to tumour ablation. J. Neurol. Neurosurg. Psychiatry, 2001, 70: 814-815.
20. Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis an therapy. Lancet Neurol., 2002, 1 (5): 294-305.
21. Yiu V.W., Kovithavongs T., Mcgnigle L.F., Ferreira P. Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome. Pediatr. Neurol., 2001, 24 (1): 72-74.
22. Zerr I., Pocchiari M., Collins S., Brandel J.P., De Pedro Cuesta J. et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology, 2000, 55: 811-815.